Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Tsitoura, E. Bibaki (bibakieleni@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), E. Vasarmidi (eirvasar@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), C. Koutoulaki (xa-ra18@gmail.com / Laboratory of Molecular and Cellular Pulmonology, M. School, U. of Crete,Heraklion), G. A. Margaritopoulos (gmargaritop@yahoo.gr / Interstitial Lung Disease Unit, R. Brompton Hospital, I. College,London), K. Karagiannis (k.karagiannis@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), A. Proklou (proklath@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), A. Trachalaki (atrachalaki@gmail.com / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), D. Moraitaki (mroitaki@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), N. Tzanakis (tzanakis@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion), A. U. Wells (rbhild@rbht.nhs.uk / Interstitial Lung Disease Unit, R. Brompton Hospital, I. College,London), K. M. Antoniou (kantoniou@med.uoc.gr / Department of Thoracic Medicine, I. Lung Disease Unit, U. Hospital,Heraklion). LSC - 2018 - AKT1/AKT2 mRNA Balance Is Significantly Different In IPF BAL Cells Compared To Other Fibrotic ILDs.. 3705

Member's Comments

No comment yet.

Related content which might interest you: Let7c and AKT1/AKT2 mRNA balance is different In IPF BAL cells compared to other fibrotic ILDs. Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Titel: MicroRNA analysis in Epithelial Lining Fluid (ELF) compared to Bronchoalveolar Lavage (BAL) in Interstitial pulmonary fibrosis (IPF) Source: International Congress 2014 – IPF and surroundings Year: 2014 Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease Source: Eur Respir J 2007; 30: Suppl. 51, 121s Year: 2007 Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Expression of miR-185 targets DNA methyltransferase 1 and Cyclin D2 in IPF and lung cancer in BALF cells: Preliminary results Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Evaluation of CD163 expression on alveolar macrophages from BAL of patients with Fibrotic Lung Diseases. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects. Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Different expression of CD44variant6 in BAL mesenchymal cells is related to BOS severity Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Levels of oxidised mitochondria in BAL macrophages in fibrotic ILDs. Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Cytokine and protein profile in BAL from patients with sarcoidosis and IPF Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 Transcriptional Profiling reveals Reprogramming of Airway Basal Cells in IPF. Source: International Congress 2017 – Novel mechanisms and therapeutic targets in lung injury and repair Year: 2017 The Transciptome of BAL Cells at Acute Exacerbation of IPF reveals New Insights. Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014 Contribute of BAL proteomic analysis in sarcoidosis (S) and in idiopathic pulmonary fibrosis (IPF/UIP) Source: Eur Respir J 2006; 28: Suppl. 50, 564s Year: 2006